Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids
Ye Yao, Han Chen, Lijing Yan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110669-110669
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
Hao Cheng, Juan Liu, Yuzhu Tan, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 4, pp. 541-555
Open Access | Times Cited: 93
Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends
Tapan Behl, Sukhbir Singh, Neelam Sharma, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3705-3705
Open Access | Times Cited: 49
Fu Brick Tea Manages HFD/STZ-Induced Type 2 Diabetes by Regulating the Gut Microbiota and Activating the IRS1/PI3K/Akt Signaling Pathway
Bangran Qi, Daoyuan Ren, Ting Li, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 27, pp. 8274-8287
Closed Access | Times Cited: 45
Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
Wenhui Liu, Zhiying Luo, Jiecan Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 38
A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant
Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1294-1294
Open Access | Times Cited: 32
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 32
Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine
Xue Zhu, Qi Yao, Pengshuo Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Baicalin ameliorates multidrug-resistant Pseudomonas aeruginosa induced pulmonary inflammation in rat via arginine biosynthesis
Lei Li, Herong Cui, Yue Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114660-114660
Open Access | Times Cited: 19
Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
Juan Huang, Nanqu Huang, Qianhua Mao, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 18
Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring
Safaa I. Khater, Taghreed N. Almanaa, Doaa M. Abdel Fattah, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1220-1220
Open Access | Times Cited: 18
Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis
Yujiao Zheng, Qiyou Ding, Yu Wei, et al.
Phytomedicine (2020) Vol. 88, pp. 153455-153455
Closed Access | Times Cited: 48
Lactobacillus casei LC89 exerts antidiabetic effects through regulating hepatic glucagon response and gut microbiota in type 2 diabetic mice
Yongli Zhang, Tao Wu, Wen Li, et al.
Food & Function (2021) Vol. 12, Iss. 18, pp. 8288-8299
Closed Access | Times Cited: 34
Lactobacillus paracaseiIMC 502 ameliorates type 2 diabetes by mediating gut microbiota–SCFA–hormone/inflammation pathway in mice
Yuxiang Gu, Hao Chen, Xing Li, et al.
Journal of the Science of Food and Agriculture (2022) Vol. 103, Iss. 6, pp. 2949-2959
Closed Access | Times Cited: 25
Regulation of the intestinal flora: A potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus
Liying He, Fangqing Yang, Pan Tang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113091-113091
Open Access | Times Cited: 22
The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes
Anna Winiarska‐Mieczan, Ewa Tomaszewska, Janine Donaldson, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2498-2498
Open Access | Times Cited: 22
Berberine influences multiple diseases by modifying gut microbiota
Fujie Yang, Rongmao Gao, Xiaoxiu Luo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 15
Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challenges
Jialiang Gao, Ting Yang, Bohan Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115395-115395
Open Access | Times Cited: 13
Impact of Berberine Hydrochloride-assisted Metformin on the Metabolism of Glycolipids and Serum Levels of TIMP-1 and TGF-β1 in Individuals with Type 2 Diabetes
Jie Yun, Yong‐Wei Zhang, Weichen Yan
Pharmacognosy Magazine (2025)
Closed Access
Comprehensive Analysis of Fecal Microbiome and Metabolomics Uncovered dl-Norvaline-Ameliorated Obesity-Associated Disorders in High-Fat Diet-Fed Obese Mice by Targeting the Gut Microbiota
Xin Li, Yanting Qin, Fangfang Yue, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Absolute Quantitative Metagenomic Analysis Provides More Accurate Insights for the Anti-Colitis Effect of Berberine via Modulation of Gut Microbiota
Jiaguo Zhan, Jiale Cheng, W. K. Chang, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 400-400
Open Access
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Mengling Yang, Yang Yang, Qingnan He, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice
Lanxiang Yang, Siping Yu, Yanhong Yang, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 55, pp. 116598-116598
Closed Access | Times Cited: 29
A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects
Vahid Reza Askari, Kimia Khosravi, Vafa Baradaran Rahimi, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 7-7
Open Access | Times Cited: 12
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
Shengjie Yang, Dan Li, Zongliang Yu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Hypoglycemic effects of Auricularia auricula polysaccharides on high fat diet and streptozotocin-induced diabetic mice using metabolomics analysis
Nannan Liu, Xuefeng Chen, Juanna Song, et al.
Food & Function (2021) Vol. 12, Iss. 20, pp. 9994-10007
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top